Search details
1.
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
N Engl J Med
; 389(8): 687-699, 2023 Aug 24.
Article
in English
| MEDLINE | ID: mdl-37486775
2.
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
Clin Infect Dis
; 76(11): 2010-2013, 2023 06 08.
Article
in English
| MEDLINE | ID: mdl-36825498
3.
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.
Clin Infect Dis
; 76(2): 323-334, 2023 01 13.
Article
in English
| MEDLINE | ID: mdl-36101518
4.
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
Clin Infect Dis
; 76(3): e613-e621, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-35975297
5.
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
Clin Infect Dis
; 77(12): 1676-1686, 2023 Dec 15.
Article
in English
| MEDLINE | ID: mdl-37439633
6.
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.
J Infect Dis
; 226(10): 1809-1822, 2022 11 11.
Article
in English
| MEDLINE | ID: mdl-35535576
7.
COVID-19 Vaccination Rates in a Global HIV Cohort.
J Infect Dis
; 225(4): 603-607, 2022 02 15.
Article
in English
| MEDLINE | ID: mdl-34794178
8.
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.
Clin Infect Dis
; 75(7): 1154-1163, 2022 09 30.
Article
in English
| MEDLINE | ID: mdl-35165682
9.
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.
Clin Infect Dis
; 75(8): 1324-1333, 2022 10 12.
Article
in English
| MEDLINE | ID: mdl-35235653
10.
Effects of HIV Infection on Arterial Endothelial Function: Results From a Large Pooled Cohort Analysis.
Arterioscler Thromb Vasc Biol
; 41(1): 512-522, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33327750
11.
Incorporating estimands into clinical trial statistical analysis plans.
Clin Trials
; 19(3): 285-291, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35257600
12.
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.
Clin Infect Dis
; 73(11): 2009-2022, 2021 12 06.
Article
in English
| MEDLINE | ID: mdl-34134131
13.
Pitavastatin and Cardiovascular Disease in HIV. Reply.
N Engl J Med
; 389(21): e46, 2023 Nov 23.
Article
in English
| MEDLINE | ID: mdl-37991868
14.
Impact of pre-existing drug resistance on risk of virological failure in South Africa.
J Antimicrob Chemother
; 76(6): 1558-1563, 2021 05 12.
Article
in English
| MEDLINE | ID: mdl-33693678
15.
Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators.
J Infect Dis
; 222(Suppl 1): S1-S7, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645161
16.
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE.
J Infect Dis
; 222(Suppl 1): S52-S62, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645163
17.
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.
J Infect Dis
; 222(Suppl 1): S41-S51, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645164
18.
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
J Infect Dis
; 222(Suppl 1): S31-S40, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645160
19.
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S8-S19, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645162
20.
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S63-S69, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645158